Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Linsitinib | 0.31623 | uM | 9 | 312.50 | 153.73 | 364.00 | 328.00 | 1.1098 | 1.1999 |
| BT-20 | Linsitinib | 0.0033113 | uM | 9 | 312.50 | 153.73 | 306.00 | 328.00 | 0.9329 | 0.8769 |
| BT-20 | 17-AAG | 0.01 | uM | 9 | 312.50 | 153.73 | 146.00 | 328.00 | 0.4451 | -0.0461 |
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 312.50 | 153.73 | 349.00 | 328.00 | 1.0640 | 1.1168 |
| BT-20 | 17-AAG | 0.001 | uM | 9 | 312.50 | 153.73 | 356.00 | 328.00 | 1.0854 | 1.1556 |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 395.00 | 328.00 | 1.2043 | 1.3706 | |
| BT-20 | 17-AAG | 0.0031623 | uM | 9 | 312.50 | 153.73 | 294.00 | 328.00 | 0.8963 | 0.8095 |
| BT-20 | Linsitinib | 1 | uM | 9 | 312.50 | 153.73 | 248.00 | 328.00 | 0.7561 | 0.5487 |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 231.00 | 328.00 | 0.7043 | 0.4513 | |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 263.00 | 328.00 | 0.8018 | 0.6342 | |
| BT-20 | Linsitinib | 19.9526 | uM | 9 | 312.50 | 153.73 | 189.00 | 328.00 | 0.5762 | 0.2080 |
| BT-20 | Linsitinib | 3.1623 | uM | 9 | 312.50 | 153.73 | 260.00 | 328.00 | 0.7927 | 0.6171 |
| BT-20 | Lapatinib | 0.0033113 | uM | 9 | 312.50 | 153.73 | 314.00 | 328.00 | 0.9573 | 0.9218 |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 312.50 | 153.73 | 444.00 | 328.00 | 1.3537 | 1.6382 |
| BT-20 | Linsitinib | 0.1 | uM | 9 | 312.50 | 153.73 | 440.00 | 328.00 | 1.3415 | 1.6165 |
| BT-20 | Lapatinib | 0.1 | uM | 9 | 312.50 | 153.73 | 423.00 | 328.00 | 1.2896 | 1.5239 |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 347.00 | 328.00 | 1.0579 | 1.1057 | |
| BT-20 | 17-AAG | 0.000066069 | uM | 9 | 312.50 | 153.73 | 423.00 | 328.00 | 1.2896 | 1.5239 |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 339.00 | 328.00 | 1.0335 | 1.0613 | |
| BT-20 | Linsitinib | 0.01 | uM | 9 | 312.50 | 153.73 | 406.00 | 328.00 | 1.2378 | 1.4309 |
| BT-20 | 17-AAG | 0.1 | uM | 9 | 312.50 | 153.73 | 117.00 | 328.00 | 0.3567 | -0.2210 |
| BT-20 | Lapatinib | 0.01 | uM | 9 | 312.50 | 153.73 | 504.00 | 328.00 | 1.5366 | 1.9625 |
| BT-20 | Lapatinib | 0.31623 | uM | 9 | 312.50 | 153.73 | 370.00 | 328.00 | 1.1280 | 1.2330 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 312.50 | 153.73 | 119.00 | 328.00 | 0.3628 | -0.2088 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 312.50 | 153.73 | 303.00 | 328.00 | 0.9238 | 0.8601 |